NexgenRx Inc.
NXG.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,964.47% | -118.01% | 369.53% | -93.19% | 220.01% |
| Total Depreciation and Amortization | 146.91% | -305.37% | -3.57% | -0.42% | 144.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -102.84% | 3,362.89% | -18.29% | -15.49% | -109.79% |
| Change in Net Operating Assets | 5.37% | -52.44% | -148.88% | 148.88% | -455.96% |
| Cash from Operations | 42.85% | 77.14% | -86.53% | 284.56% | -233.69% |
| Capital Expenditure | -15.05% | -267.86% | 75.11% | -64.23% | -57.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 76.09% | -310.53% | 53.31% | -200.00% | -- |
| Cash from Investing | 66.70% | -305.68% | 57.54% | -158.57% | -416.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.68% | -16.98% | -9.96% | -16.43% | 24.18% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 68.41% | -200.83% | 91.46% | -1,056.33% | 92.04% |
| Other Financing Activities | -- | 200.00% | -200.00% | -- | -- |
| Cash from Financing | 34.59% | -224.55% | 92.05% | -623.25% | 116.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 233.33% | -486.38% | -92.16% | 185.70% | -759.55% |